Current and historical daily PE Ratio for Syncom Formulation (India) Ltd (
) from 2000 to May 20 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Syncom Formulation (India) stock (BOM:524470) PE ratio as of May 20 2024 is 39.53.
More Details
Syncom Formulation (India) Ltd (BOM:524470) PE Ratio (TTM) Chart
Syncom Formulation (India) Ltd (BOM:524470) PE Ratio (TTM) Historical Data
View and export this data going back to 2000. Start your Free Trial
Total 1223
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Syncom Formulation (India) PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-20 | 39.5 | 2024-03-07 | 39.8 |
| 2024-05-17 | 39.5 | 2024-03-06 | 37.9 |
| 2024-05-16 | 39.8 | 2024-03-05 | 39.6 |
| 2024-05-15 | 40.0 | 2024-03-04 | 40.9 |
| 2024-05-14 | 40.3 | 2024-03-01 | 42.0 |
| 2024-05-13 | 38.4 | 2024-02-29 | 43.0 |
| 2024-05-10 | 38.4 | 2024-02-28 | 41.7 |
| 2024-05-09 | 38.2 | 2024-02-27 | 43.8 |
| 2024-05-08 | 39.2 | 2024-02-26 | 44.0 |
| 2024-05-07 | 39.1 | 2024-02-23 | 44.6 |
| 2024-05-06 | 39.8 | 2024-02-22 | 45.2 |
| 2024-05-03 | 41.0 | 2024-02-21 | 45.7 |
| 2024-05-02 | 41.1 | 2024-02-20 | 46.8 |
| 2024-04-30 | 40.2 | 2024-02-19 | 46.8 |
| 2024-04-29 | 40.7 | 2024-02-16 | 44.6 |
| 2024-04-26 | 40.6 | 2024-02-15 | 45.3 |
| 2024-04-25 | 40.5 | 2024-02-14 | 45.8 |
| 2024-04-24 | 41.3 | 2024-02-13 | 44.4 |
| 2024-04-23 | 40.8 | 2024-02-12 | 45.4 |
| 2024-04-22 | 38.9 | 2024-02-09 | 46.4 |
| 2024-04-19 | 37.0 | 2024-02-08 | 45.9 |
| 2024-04-18 | 37.3 | 2024-02-07 | 46.5 |
| 2024-04-16 | 37.2 | 2024-02-06 | 46.4 |
| 2024-04-15 | 36.2 | 2024-02-05 | 46.3 |
| 2024-04-12 | 37.9 | 2024-02-02 | 46.2 |
| 2024-04-10 | 38.8 | 2024-02-01 | 46.6 |
| 2024-04-09 | 39.0 | 2024-01-31 | 47.7 |
| 2024-04-08 | 40.7 | 2024-01-30 | 49.3 |
| 2024-04-05 | 40.0 | 2024-01-29 | 45.2 |
| 2024-04-04 | 39.9 | 2024-01-25 | 44.8 |
| 2024-04-03 | 38.0 | 2024-01-24 | 45.2 |
| 2024-04-02 | 36.2 | 2024-01-23 | 44.4 |
| 2024-04-01 | 34.5 | 2024-01-19 | 46.1 |
| 2024-03-28 | 32.9 | 2024-01-18 | 44.9 |
| 2024-03-27 | 32.6 | 2024-01-17 | 45.0 |
| 2024-03-26 | 34.1 | 2024-01-16 | 45.9 |
| 2024-03-22 | 35.1 | 2024-01-15 | 46.9 |
| 2024-03-21 | 34.9 | 2024-01-12 | 48.1 |
| 2024-03-20 | 34.2 | 2024-01-11 | 48.7 |
| 2024-03-19 | 35.1 | 2024-01-10 | 48.9 |
| 2024-03-18 | 35.5 | 2024-01-09 | 51.4 |
| 2024-03-14 | 36.5 | 2024-01-08 | 52.2 |
| 2024-03-13 | 35.5 | 2024-01-05 | 46.1 |
| 2024-03-12 | 37.4 | 2024-01-04 | 46.3 |
| 2024-03-11 | 39.3 | 2024-01-03 | 46.3 |
Syncom Formulation (India) Ltd (BOM:524470) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Syncom Formulation (India) Ltd
ISIN : INE312C01025
Compare
Compare
Traded in other countries / regions
SYNCOMF.India IPO Date
2000-11-20Description
Syncom Formulation (India) Ltd is in the business of pharmaceuticals. The company operates through three segments including manufacturing and dealings in Pharmaceutical drugs and formulations, Trading of commodities, and Renting of property. It manufactures and markets pharmaceutical formulation products in various dosage forms like tablets, capsules, liquids orals, liquids vials, ampoule injections and dry vial injections, dry syrups, ointments, inhalers, and Herbals. The company's product includes generic, antiviral, antidepressant, cough suppressant, electrolyte, histamine, estrogen, and much more. It generates maximum revenue through the Pharmaceutical drugs and formulations segment.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers